The Study of Oral Sustained Release Dosage Forms of Nifedipine by Matrix Concentration Gradient Method

碩士 === 國防醫學院 === 藥學研究所 === 86 ===   Nifedipine, a calcium channel-blocking agent, has widely been used for the treatment of hypertention and coronary heart disease. Because it's half-life is 2-3 hours, we can take the long-term sustained release dosage form to increase the duration and avoid t...

Full description

Bibliographic Details
Main Author: 孟仲麟
Other Authors: 王大鵬
Format: Others
Language:zh-TW
Published: 1998
Online Access:http://ndltd.ncl.edu.tw/handle/83745342388710674541
id ndltd-TW-086NDMC3551003
record_format oai_dc
spelling ndltd-TW-086NDMC35510032015-10-13T11:06:20Z http://ndltd.ncl.edu.tw/handle/83745342388710674541 The Study of Oral Sustained Release Dosage Forms of Nifedipine by Matrix Concentration Gradient Method 質粒梯度濃囿k製備Nifedipine口服持續釋出劑型之研究 孟仲麟 碩士 國防醫學院 藥學研究所 86   Nifedipine, a calcium channel-blocking agent, has widely been used for the treatment of hypertention and coronary heart disease. Because it's half-life is 2-3 hours, we can take the long-term sustained release dosage form to increase the duration and avoid the suddenly change of plasma drug concentration.   The objective of this study was to use the non-uniform drug concentration method for preparing oral dosage form of nifedipine with zero-order release. We use two peristaltic pumps, one pumps the matrix solution of vessel A to vessel B, which contains the nifedipine and matrix solution (the pump rate is Ki). The other one pumps drug solution from vessel B to the rotary fluid-bed (the pump rate is Ko).   The main formulation parameters we discuss are (1) the content of ethylcellulose (2) the incorporate amount of water soluble sucrose (3) the change of pump ratio Ki/(Ko-Ki). The dissolution test follow the USP X X III paddle method and use 1.5% (w/v) Tween 80 in the dissolution medium to maintain "sink condition". From the drug dissolution profile, we use the zero-order fitting model and the final release percent of nifedipine within 12 hours as the criteria to optimize the formulation.   The data indicate that (1) Increase of ethylcellulose amount will decrease the dissolution release rate constant when we fix the pump ratio. (2) Incorporation of water soluble sucrose will increase the total drug release percent, and the zero-order linearity is not change significantly. (3) Increase of pump ratio will decrease the release rate constant. Finally, we successfully select a formulation which correlation coefficient is 0.99055 and the final release percent is up pto 85%. In animal tests, proved that our sustained release formulation was successfully. 王大鵬 1998 學位論文 ; thesis 85 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國防醫學院 === 藥學研究所 === 86 ===   Nifedipine, a calcium channel-blocking agent, has widely been used for the treatment of hypertention and coronary heart disease. Because it's half-life is 2-3 hours, we can take the long-term sustained release dosage form to increase the duration and avoid the suddenly change of plasma drug concentration.   The objective of this study was to use the non-uniform drug concentration method for preparing oral dosage form of nifedipine with zero-order release. We use two peristaltic pumps, one pumps the matrix solution of vessel A to vessel B, which contains the nifedipine and matrix solution (the pump rate is Ki). The other one pumps drug solution from vessel B to the rotary fluid-bed (the pump rate is Ko).   The main formulation parameters we discuss are (1) the content of ethylcellulose (2) the incorporate amount of water soluble sucrose (3) the change of pump ratio Ki/(Ko-Ki). The dissolution test follow the USP X X III paddle method and use 1.5% (w/v) Tween 80 in the dissolution medium to maintain "sink condition". From the drug dissolution profile, we use the zero-order fitting model and the final release percent of nifedipine within 12 hours as the criteria to optimize the formulation.   The data indicate that (1) Increase of ethylcellulose amount will decrease the dissolution release rate constant when we fix the pump ratio. (2) Incorporation of water soluble sucrose will increase the total drug release percent, and the zero-order linearity is not change significantly. (3) Increase of pump ratio will decrease the release rate constant. Finally, we successfully select a formulation which correlation coefficient is 0.99055 and the final release percent is up pto 85%. In animal tests, proved that our sustained release formulation was successfully.
author2 王大鵬
author_facet 王大鵬
孟仲麟
author 孟仲麟
spellingShingle 孟仲麟
The Study of Oral Sustained Release Dosage Forms of Nifedipine by Matrix Concentration Gradient Method
author_sort 孟仲麟
title The Study of Oral Sustained Release Dosage Forms of Nifedipine by Matrix Concentration Gradient Method
title_short The Study of Oral Sustained Release Dosage Forms of Nifedipine by Matrix Concentration Gradient Method
title_full The Study of Oral Sustained Release Dosage Forms of Nifedipine by Matrix Concentration Gradient Method
title_fullStr The Study of Oral Sustained Release Dosage Forms of Nifedipine by Matrix Concentration Gradient Method
title_full_unstemmed The Study of Oral Sustained Release Dosage Forms of Nifedipine by Matrix Concentration Gradient Method
title_sort study of oral sustained release dosage forms of nifedipine by matrix concentration gradient method
publishDate 1998
url http://ndltd.ncl.edu.tw/handle/83745342388710674541
work_keys_str_mv AT mèngzhònglín thestudyoforalsustainedreleasedosageformsofnifedipinebymatrixconcentrationgradientmethod
AT mèngzhònglín zhìlìtīdùnóngyòukzhìbèinifedipinekǒufúchíxùshìchūjìxíngzhīyánjiū
AT mèngzhònglín studyoforalsustainedreleasedosageformsofnifedipinebymatrixconcentrationgradientmethod
_version_ 1716839146015686656